Clinical Trial Update: Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update: The Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Vessel Cerebrovascular Disease

Snippet

Sponsor: University of Oxford | Conditions: Small Vessel Cerebrovascular Disease | Phase 2 | Status: COMPLETED